Multiplexing of Receptor Occupancy Measurements for Pharmacodynamic Biomarker Assessment of Biopharmaceuticals

Cytometry Part B - Clinical Cytometry - United States
doi 10.1002/cyto.b.21319
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Homogeneous BTK Occupancy Assay for Pharmacodynamic Assessment of Tirabrutinib (GS-4059/ONO-4059) Target Engagement

SLAS Discovery
BiochemistryBiotechnologyAnalytical ChemistryMolecular Medicine
2018English

Development and Validation of Biomarker Assays to Assess Pharmacodynamic Modulation of MET.

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
2011English

Enhancing Studies of Pharmacodynamic Mechanisms via Measurements of Metabolic Flux.

Journal of Pharmacology and Experimental Therapeutics
Molecular MedicinePharmacology
2017English

Comparisons of Analysis Methods for Assessment of Pharmacodynamic Interactions Including Design Recommendations

AAPS Journal
Pharmaceutical Science
2018English

Treatment-Related Hypertension as a Pharmacodynamic Biomarker for the Efficacy of Bevacizumab in Advanced Pancreas Cancer

American Journal of Clinical Oncology: Cancer Clinical Trials
Cancer ResearchOncology
2016English

Instrument for Objective Assessment of Appropriateness of Surgical Bed Occupancy: Validation Study

BMJ
2003English

Insurance Coverage of Biopharmaceuticals

Health Affairs
MedicineHealth Policy
2006English

Receptor Occupancy and Channel-Opening Kinetics

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2007English

Microbial Quality Concerns for Biopharmaceuticals

2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy